National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2020 (No. 9) (PB 103 of 2020) (Cth)

PB 103 of 2020

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2020
(No. 9)

National Health Act 1953

___________________________________________________________________________

I, PAUL HANSEN, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated         29 October 2020

PAUL HANSEN

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2020 (No. 9).

(2)This Instrument may also be cited as PB 103 of 2020.

1. Commencement

This Instrument commences on 1 November 2020.

1. Amendment of National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1       Amendments

1. Schedule 1, omit entry for Aurothiomalate

1. Schedule 1, entry for Nifedipine

omit:

Tablet 20 mg (controlled release) 20 30 5

1. Schedule 1, entry for Phenoxybenzamine

omit:

Capsule containing 10 mg phenoxybenzamine hydrochloride 20 100 5

1. Schedule 1, after entry for Simvastatin in the form Tablet 80 mg

insert:

Siponimod	Tablet 250 micrograms (as hemifumarate)	20	120	5
Tablet 2 mg (as hemifumarate)	20	28	5

1. Schedule 1, omit entry for Sofosbuvir